About Novel Laboratories
Novel Laboratories is a Healthcare company based in Somerset (United States) founded in 2006, and was acquired by Lupin Pharmaceuticals in July 2015. ANDA dosage forms and delivery systems are developed and manufactured. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Novel Laboratories was founded in 2006 in Somerset, United States. ANDA dosage forms and delivery systems are developed and manufactured by the company within the generic pharmaceuticals sector. Product approvals, including ANDAs, first-to-file submissions, and confirmed Paragraph IV certifications, have been obtained. Generic pharmaceuticals are sold through its affiliate, GAVIS Pharmaceuticals. The company and its affiliate were acquired by Lupin in July 2015.
- Headquarters Somerset, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website novellabs.net
- Social LinkedIn
- Acquired by Lupin Pharmaceuticals (Jul 2015)
- Investors
- Acquired byLupin Pharmaceuticals
(Jul 2015)
Investors in Novel Laboratories
Novel Laboratories has secured backing from 1 investor. Prominent investors backing the company include Lupin Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
APIs, generics, and specialty pharma products are manufactured and marketed. | 1968 | lupinpharmaceuticals.com | Baltimore, United States |
Investor details for Novel Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Novel Laboratories
2 dated milestones of Novel Laboratories across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Novel Laboratories is founded.
- Exit Acquired by Lupin Pharmaceuticals.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Novel Laboratories (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Novel Laboratories
Novel Laboratories was founded in 2006.
Novel Laboratories is headquartered in Somerset, United States.
Novel Laboratories was founded in 2006 in Somerset, United States. ANDA dosage forms and delivery systems are developed and manufactured by the company within the generic pharmaceuticals sector. Product approvals, including ANDAs, first-to-file submissions, and confirmed Paragraph IV certifications, have been obtained. Generic pharmaceuticals are sold through its affiliate, GAVIS Pharmaceuticals. The company and its affiliate were acquired by Lupin in July 2015.
Novel Laboratories has 1 investor. Key investors include Lupin Pharmaceuticals.
Yes. Novel Laboratories was acquired by Lupin Pharmaceuticals in July 2015.
